Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

Annals of Neurology

Volumn 42, Issue 1, 1997, Pages 95-107

  Wenning, Gregor K ^a   Odin, Per ^d   Morrish, Paul ^c   Rehncrona, Stig ^d   Widner, Håkan ^d,e   Brundin, Patrik ^e   Rothwell, John C ^b   Brown, Richard ^b   Gustavii, Björn ^d   Hagell, Peter ^d   Jahanshahi, Marjan ^b   Sawle, Guy ^c   Björklund, Anders ^e   Brooks, David J ^c   Marsden, C David ^a,b   Quinn, Niall P ^a   Lindvall, Olle ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; ARTICLE; BRAIN TRANSPLANTATION; CAUDATE NUCLEUS; CLINICAL ARTICLE; DOPAMINERGIC NERVE CELL; DYSKINESIA; EMBRYO; GRAFT SURVIVAL; HUMAN; HYPOKINESIA; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RIGIDITY; TEGMENTUM; TISSUE GRAFT;

EID: 0030834093     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420115     Document Type: Article

References (25)

1. Lindvall O. Neural transplantation in Parkinson's disease. In: Dunnett SB, Björklund A, eds. Functional neural transplantation. New York: Raven, 1994:103-137
2. Olanow CW, Kordower JH, Freeman TB. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 1996;19:102-109
3. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990;247:574-577
4. Freeman TB, Olanow CW, Hauser RA, et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 1995;38:379-388
5. Lindvall O, Widner H, Rehncrona S, et al. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol 1992;31:155-165
6. Lindvall O, Sawle G, Widner H, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Aim Neurol 1994;35:172-180
7. 18F]-6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol 1992;31:166-173
8. Widner H, Tetrud J, Rehncrona S, et al. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 1992;327:1556-1563
9. 18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 1995;38:580-588
10. Kordower JH, Freeman TB, Snow BJ, et al. Neuropathologic evidence of graft survival and striatal reinnervation after transplantation of fetal nigral tissue in a patient with Parkinson's disease. N Engl J Med 1995;332:1118-1124
11. Kordower JH, Rosenstein JM, Collier TJ, et al. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 1996;370:203-230
12. Peschanski M, Defer G, N'Guyen JP, et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 1994;177:487-499
13. Defer GL, Geny C, Ricolfi F, et al. Long-term outcome of unilaterally transplanted parkinsonian patients: I. Clinical approach. Brain 1996;119:41-50
14. Lindvall O, Rehncrona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: a detailed account of methodology and a 6-month follow-up. Arch Neurol 1989;46:615-631
15. Langsten JW, Widner H, Goetz CG, et al. Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord 1992;7:2-13
16. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967:17:427-442
17. Olanow CW. Magnetic resonance imaging in parkinsonism. Neurol Clin 1992;10:405-420
18. Konagaya M, Konagaya Y, Iida M. Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy. J Neurol Neurosurg Psychiatry 1994;57:1528-1531
19. Vingerhoets FJ, Snow BJ, Schulzer M, et al. Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects. J Nucl Med 1994;35:18-24
20. Ceballos-Baumann AO, Jenkins IH, Morrish PK, et al. Increase of movement related activation of the supplementary motor area after embryonic mesencephalic grafting in Parkinson's disease. Neurology 1996;46(Suppl A):458
21. Brooks DJ, Jenkins IH, Passingham RE. Positron emission tomography studies on regional cerebral control of voluntary movement. In: Mano N, Hamada I, Delong MR, eds. Role of the cerebellum and basal ganglia in voluntary movement. New York: Excerpta Medica, 1993:267-274
22. Eardley I, Quinn NP, Fowler CJ, et al. The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. Br J Urol 1989;64:360-362
23. Nutt JG. Levodopa-induced dyskinesia: review, observations, and speculations. Neurology 1990;40:340-345
24. Bravi D, Mouradian MM, Roberts JW, et al. Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms. Ann Neurol 1994;36:27-31
25. Albin RL. The pathophysiology of chorea/ballism and parkinsonism. Parkinsons Related Disord 1995;1:1-11